Guardant Health GH Income Statement (2017-2026)

NASDAQ GH
$168.40 -2.51 (-1.47%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Guardant Health Quarterly Income Statement

Periods 36 quarters
Latest Jun 2026

Guardant Health reported revenue of $334.98M and net income of -$120.14M for the quarter ended Jun 2026, up 44.3% year over year. This income statement covers 36 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
94.78M108.11M96.10M109.14M117.40M126.89M128.71M137.15M143.03M155.05M168.49M177.24M191.48M201.81M203.47M232.09M265.20M281.27M301.67M334.98M
Cost of RevenueCost of Rev
65.30M72.42M74.49M77.59M74.72M81.20M93.59M99.49M104.92M115.95M
Gross Profit
103.19M104.81M116.99M124.22M128.75M150.88M171.61M181.77M196.75M219.03M
Operating items
Research & DevelopmentR&D
70.97M73.02M81.76M85.45M100.02M106.58M93.13M90.36M93.85M89.86M83.80M83.10M97.88M104.76M104.32M119.59M127.38M143.38M169.13M189.95M
Selling, General & AdministrativeSG&A
50.05M40.27M41.27M43.68M41.12M37.89M40.45M41.52M36.17M37.66M38.65M40.46M49.13M51.88M46.95M50.26M53.27M60.93M57.93M61.66M
Other Operating ExpensesOther Opex
81.04M93.02M96.41M110.33M120.87M128.54M129.20M124.89M126.55M225.04M145.72M154.29M161.79M171.14M163.24M168.65M183.54M197.76M195.96M212.48M
Operating ExpensesOpex
202.07M206.32M219.44M239.47M262.00M273.01M262.77M256.77M256.57M352.56M268.17M277.85M308.80M327.78M314.51M338.50M364.19M402.07M423.01M464.10M
Operating IncomeOp. Inc
-107.29M-98.21M-123.34M-130.32M-144.60M-146.12M-134.06M-119.62M-113.54M-197.51M-99.68M-100.62M-117.33M-125.97M-111.04M-106.41M-98.99M-120.81M-121.35M-129.12M
EBIT
-107.29M-98.21M-123.34M-130.32M-144.60M-146.12M-134.06M-119.62M-113.54M-197.51M-99.68M-100.62M-117.33M-125.97M-111.04M-106.41M-98.99M-120.81M-121.35M-129.12M
Non-operating items
Non Operating Interest Expenses
0.64M0.64M0.64M0.65M0.64M0.64M0.64M0.65M0.64M0.65M0.65M0.65M0.65M0.65M0.79M0.98M0.94M1.18M1.35M1.35M
Interest & Investment IncomeInt & Inv Inc
0.69M0.65M0.78M1.39M1.75M2.15M3.06M6.73M11.69M13.89M14.87M13.91M13.26M11.65M9.11M7.56M7.39M10.03M11.15M10.20M
Other Non Operating IncomeOther Non Op Inc.
-0.19M25.90M-0.05M0.38M-18.39M5.28M-1.65M41.26M16.89M-3.32M-29.12M-15.14M-3.01M4.67M7.85M-0.03M-0.05M-18.27M-0.16M0.31M
Net income details
EBT
-107.43M-72.30M-123.25M-228.99M-161.88M-139.33M-133.29M-72.28M-85.61M-187.58M-114.58M-102.50M-107.72M-110.29M-94.87M-99.86M-92.59M-130.22M-111.70M-119.96M
Tax ProvisionsTaxes
0.10M0.01M-0.02M0.45M0.12M0.60M0.24M0.50M0.49M-0.54M0.41M0.13M0.03M0.72M0.29M0.04M0.14M-1.73M0.37M0.18M
Profit After TaxPAT
-107.53M-90.91M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Income from Non-Controlling InterestsInc. Minority
18.60M
Income from Continuing OperationsIncome (Continuing)
-107.53M-72.31M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Consolidated Net IncomeConsol Net Inc.
-107.53M-72.31M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Income towards Parent CompanyParent Net Inc
-107.53M-72.31M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-107.53M-90.91M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Additional items
EPS (Basic)
-1.06-0.90-1.21-2.25-1.58-1.37-1.30-0.67-0.73-1.67-0.94-0.84-0.88-0.90-0.77-0.80-0.74-1.02-0.85-0.90
EPS (Diluted)
-1.06-0.90-1.21-2.25-1.58-1.37-1.30-0.67-0.73-1.67-0.94-0.84-0.88-0.90-0.77-0.80-0.74-1.02-0.85-0.90
Shares Outstanding
101.42M101.31M101.85M102.05M102.29M102.18M102.66M108.81M117.74M111.99M121.71M122.45M123.05M122.75M123.87M124.11M124.81M125.37M131.27M132.87M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
101.42M101.31M101.85M102.05M102.29M102.18M102.66M108.81M117.74M111.99M121.71M122.45M123.05M122.75M123.87M124.11M124.81M125.37M131.27M132.87M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
101.62M101.77M101.90M102.19M102.41M102.62M102.71M117.66M117.85M121.63M121.79M122.97M123.16M123.99M123.65M124.48M125.01M130.64M131.51M133.61M
EBITDA
-107.29M-98.21M-123.34M-130.32M-144.60M-146.12M-134.06M-119.62M-113.54M-197.51M-99.68M-100.62M-117.33M-125.97M-111.04M-106.41M-98.99M-120.81M-121.35M-129.12M
Interest ExpensesInt Expense
0.64M0.64M0.64M0.65M0.64M0.64M0.64M0.65M0.64M0.65M0.65M0.65M0.65M0.65M0.79M0.98M0.94M1.18M1.35M1.35M
Tax Rate
-0.09%-0.02%0.02%-0.19%-0.07%-0.43%-0.18%-0.69%-0.57%0.29%-0.35%-0.13%-0.03%-0.65%-0.31%-0.04%-0.15%1.33%-0.33%-0.15%